1. Caniggia A., A. Vattimo: Kinetics of technetium-99m-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism. Calcif. Tissue Int. 30: 5–13 (1980).
2. Davie M.W.J., J.M. Britton, M. Haddaway, I.W. McCall: “””Tc-MDP retention in osteoporosis: relationship to other indices of bone cell activity and response to calcium and vitamin D therapy. Eur. J. Nucl. Med. 13: 462–466 (1987).
3. Fogelman I., R.G. Bessent, J.G. Turner, D.L. Citrin, I.T. Boyle, W.R. Greig: The use of whole body retention of 99mTc-diphosphonate in the diagnosis of metabolic bone disease. J. Nucl. Med. 19: 270–275 (1978).
4. Fogelman I., R.G. Bessent, H.N. Cohen, D.M. Hart: Skeletal uptake of diphosphonate. Method for prediction of postmenopausal osteoporosis. Lancet 2: 667–670 (1980).
5. Galasko C.S.B.: The pathological basis for skeletal scintigraphy. J. Bone Joint Surg. [B] 57: 353–359 (1975).